Breaking News Instant updates and real-time market news.

MYOV

Myovant Sciences

$7.90 /

+0.92 (+13.18%)

12:00
08/19/19
08/19
12:00
08/19/19
12:00

Myovant Sciences rises 13.1%

Myovant Sciences is up 13.1%, or 92c to $7.92.

MYOV Myovant Sciences
$7.90 /

+0.92 (+13.18%)

08/19/19
SVB Leerink bullish on Myovant Sciences, initiates with an Outperform
08/19/19 SVB Leerink
Myovant Sciences initiated with an Outperform at SVB Leerink
05/30/19 Citi
Myovant Sciences assumed with a Buy at Citi
05/29/19 JPMorgan
Myovant Sciences shares oversold at current levels, says JPMorgan

TODAY'S FREE FLY STORIES

Hot Stocks
Omeros reports recovery, survival of all COVID patients in study of narsoplimab » 07:38
08/10/20
08/10
07:38
08/10/20
07:38
OMER

Omeros

$14.13 /

+0.12 (+0.86%)

Omeros said in a release,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
OMER Omeros
$14.13 /

+0.12 (+0.86%)

OMER Omeros
$14.13 /

+0.12 (+0.86%)

03/04/20 Wedbush
Omeros price target raised to $22 from $18 at Wedbush
03/03/20 Cantor Fitzgerald
Omeros shares can 'significantly rerate' from here, says Cantor Fitzgerald
11/05/19 H.C. Wainwright
Omeros recent selloff appears unwarranted, says H.C. Wainwright
OMER Omeros
$14.13 /

+0.12 (+0.86%)

  • 05
    Dec
OMER Omeros
$14.13 /

+0.12 (+0.86%)

Hot Stocks
Navidea, Jubilant sign MOU worth $19M for Rheumatoid Arthritis Diagnostic ELDA » 07:38
08/10/20
08/10
07:38
08/10/20
07:38
NAVB

Navidea

$4.71 /

-0.09 (-1.88%)

Navidea announced that it…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NAVB Navidea
$4.71 /

-0.09 (-1.88%)

NAVB Navidea
$4.71 /

-0.09 (-1.88%)

05/22/20 H.C. Wainwright
Navidea price target raised to $6 from $4 at H.C. Wainwright
11/22/19 H.C. Wainwright
Navidea initiated with a Buy at H.C. Wainwright
NAVB Navidea
$4.71 /

-0.09 (-1.88%)

Hot Stocks
Axsome Therapeutics expects cash to fund operations for at least two years » 07:38
08/10/20
08/10
07:38
08/10/20
07:38
AXSM

Axsome Therapeutics

$78.20 /

+0.14 (+0.18%)

Axsome believes that its…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AXSM Axsome Therapeutics
$78.20 /

+0.14 (+0.18%)

AXSM Axsome Therapeutics
$78.20 /

+0.14 (+0.18%)

07/13/20 Oppenheimer
Relmada Therapeutics initiated with an Outperform at Oppenheimer
04/28/20 Guggenheim
Axsome Therapeutics price target raised to $200 from $158 at Guggenheim
04/28/20 SunTrust
Axsome Therapeutics price target raised to $200 from $145 at SunTrust
04/28/20 Cantor Fitzgerald
Axsome Therapeutics price target raised to $131 from $125 at Cantor Fitzgerald
AXSM Axsome Therapeutics
$78.20 /

+0.14 (+0.18%)

  • 19
    Dec
AXSM Axsome Therapeutics
$78.20 /

+0.14 (+0.18%)

AXSM Axsome Therapeutics
$78.20 /

+0.14 (+0.18%)

Recommendations
Mr. Cooper price target raised to $24 from $16 at Credit Suisse » 07:38
08/10/20
08/10
07:38
08/10/20
07:38
COOP

Mr. Cooper

$17.98 /

-0.26 (-1.43%)

Credit Suisse analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
COOP Mr. Cooper
$17.98 /

-0.26 (-1.43%)

COOP Mr. Cooper
$17.98 /

-0.26 (-1.43%)

08/03/20 Piper Sandler
Mr. Cooper price target raised to $25 from $15 at Piper Sandler
07/31/20 Barclays
Barclays upgrades Mr. Cooper to Overweight with refis in 'earlier innings'
07/31/20 Barclays
Mr. Cooper upgraded to Overweight from Equal Weight at Barclays
07/07/20 KeyBanc
Mr. Cooper price target raised to $14 from $12 at KeyBanc
COOP Mr. Cooper
$17.98 /

-0.26 (-1.43%)

COOP Mr. Cooper
$17.98 /

-0.26 (-1.43%)

Hot Stocks
Axsome Therapeutics announces anticipated milestones » 07:37
08/10/20
08/10
07:37
08/10/20
07:37
AXSM

Axsome Therapeutics

$78.20 /

+0.14 (+0.18%)

Anticipated Milestones:…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AXSM Axsome Therapeutics
$78.20 /

+0.14 (+0.18%)

AXSM Axsome Therapeutics
$78.20 /

+0.14 (+0.18%)

07/13/20 Oppenheimer
Relmada Therapeutics initiated with an Outperform at Oppenheimer
04/28/20 Guggenheim
Axsome Therapeutics price target raised to $200 from $158 at Guggenheim
04/28/20 SunTrust
Axsome Therapeutics price target raised to $200 from $145 at SunTrust
04/28/20 Cantor Fitzgerald
Axsome Therapeutics price target raised to $131 from $125 at Cantor Fitzgerald
AXSM Axsome Therapeutics
$78.20 /

+0.14 (+0.18%)

  • 19
    Dec
AXSM Axsome Therapeutics
$78.20 /

+0.14 (+0.18%)

AXSM Axsome Therapeutics
$78.20 /

+0.14 (+0.18%)

Recommendations
AmerisourceBergen price target raised to $118 from $111 at Credit Suisse » 07:36
08/10/20
08/10
07:36
08/10/20
07:36
ABC

AmerisourceBergen

$102.10 /

+0.5 (+0.49%)

Credit Suisse analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ABC AmerisourceBergen
$102.10 /

+0.5 (+0.49%)

ABC AmerisourceBergen
$102.10 /

+0.5 (+0.49%)

06/15/20 Morgan Stanley
Morgan Stanley upgrades AmerisourceBergen on opioid settlement potential
06/15/20 Morgan Stanley
AmerisourceBergen upgraded to Overweight from Equal Weight at Morgan Stanley
05/22/20 Wolfe Research
McKesson upgraded to Outperform from Peer Perform at Wolfe Research
05/18/20 Argus
Argus sees long term growth opportunities for AmerisourceBergen
ABC AmerisourceBergen
$102.10 /

+0.5 (+0.49%)

ABC AmerisourceBergen
$102.10 /

+0.5 (+0.49%)

ABC AmerisourceBergen
$102.10 /

+0.5 (+0.49%)

ABC AmerisourceBergen
$102.10 /

+0.5 (+0.49%)

Earnings
Axsome Therapeutics reports Q2 EPS (49c), consensus (62c) » 07:36
08/10/20
08/10
07:36
08/10/20
07:36
AXSM

Axsome Therapeutics

$78.20 /

+0.14 (+0.18%)

"Axsome is committed…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AXSM Axsome Therapeutics
$78.20 /

+0.14 (+0.18%)

AXSM Axsome Therapeutics
$78.20 /

+0.14 (+0.18%)

07/13/20 Oppenheimer
Relmada Therapeutics initiated with an Outperform at Oppenheimer
04/28/20 Guggenheim
Axsome Therapeutics price target raised to $200 from $158 at Guggenheim
04/28/20 SunTrust
Axsome Therapeutics price target raised to $200 from $145 at SunTrust
04/28/20 Cantor Fitzgerald
Axsome Therapeutics price target raised to $131 from $125 at Cantor Fitzgerald
AXSM Axsome Therapeutics
$78.20 /

+0.14 (+0.18%)

  • 19
    Dec
AXSM Axsome Therapeutics
$78.20 /

+0.14 (+0.18%)

AXSM Axsome Therapeutics
$78.20 /

+0.14 (+0.18%)

Recommendations
Etsy price target raised to $160 from $90 at DA Davidson » 07:35
08/10/20
08/10
07:35
08/10/20
07:35
ETSY

Etsy

$135.21 /

+4.55 (+3.48%)

DA Davidson analyst Tom…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ETSY Etsy
$135.21 /

+4.55 (+3.48%)

ETSY Etsy
$135.21 /

+4.55 (+3.48%)

08/06/20 KeyBanc
Etsy price target raised to $150 from $115 at KeyBanc
08/06/20
Fly Intel: Top five analyst upgrades
08/06/20 Morgan Stanley
Morgan Stanley stays Underweight on Etsy, wonder is this 'as good as it gets?'
08/06/20 Truist
Etsy price target raised to $162 from $112 at Truist
ETSY Etsy
$135.21 /

+4.55 (+3.48%)

ETSY Etsy
$135.21 /

+4.55 (+3.48%)

ETSY Etsy
$135.21 /

+4.55 (+3.48%)

ETSY Etsy
$135.21 /

+4.55 (+3.48%)

Hot Stocks
Synchronoss sees 2020 adjusted EBITDA $20M-$25M » 07:35
08/10/20
08/10
07:35
08/10/20
07:35
SNCR

Synchronoss

$3.08 /

+0.02 (+0.65%)

The company's…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SNCR Synchronoss
$3.08 /

+0.02 (+0.65%)

SNCR Synchronoss
$3.08 /

+0.02 (+0.65%)

07/16/20 Northland
Northland says AT&T cloud could become Synchronoss' second largest customer
05/26/20 Northland
Synchronoss initiated with an Outperform at Northland
05/11/20 Roth Capital
Synchronoss price target lowered to $9 from $13 at Roth Capital
12/20/19 Roth Capital
Roth says Synchronoss opportunity in advanced messaging looks underappreciated
SNCR Synchronoss
$3.08 /

+0.02 (+0.65%)

Upgrade
Pinterest upgraded to Overweight on social shopping trend at Morgan Stanley » 07:35
08/10/20
08/10
07:35
08/10/20
07:35
PINS

Pinterest

$35.04 /

-0.85 (-2.37%)

, FB

Facebook

$268.52 /

+3.295 (+1.24%)

As previously reported,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PINS Pinterest
$35.04 /

-0.85 (-2.37%)

FB Facebook
$268.52 /

+3.295 (+1.24%)

PINS Pinterest
$35.04 /

-0.85 (-2.37%)

07:01 Today Morgan Stanley
Pinterest upgraded to Overweight from Equal Weight at Morgan Stanley
08/03/20
Fly Intel: Top five analyst upgrades
08/03/20 Wedbush
Pinterest price target raised to $39 from $31 at Wedbush
08/03/20 DA Davidson
Pinterest price target raised to $28 from $19 at DA Davidson
FB Facebook
$268.52 /

+3.295 (+1.24%)

06:55 Today Mizuho
Facebook price target raised to $315 from $285 at Mizuho
08/05/20 HSBC
HSBC bumps up Facebook target to $195, maintains Reduce rating
08/04/20 Argus
Facebook price target raised to $300 from $270 at Argus
08/03/20 Wedbush
Wedbush sees a TikTok deal as big bet from Microsoft on social media space
PINS Pinterest
$35.04 /

-0.85 (-2.37%)

FB Facebook
$268.52 /

+3.295 (+1.24%)

  • 16
    Oct
PINS Pinterest
$35.04 /

-0.85 (-2.37%)

FB Facebook
$268.52 /

+3.295 (+1.24%)

PINS Pinterest
$35.04 /

-0.85 (-2.37%)

FB Facebook
$268.52 /

+3.295 (+1.24%)

PINS Pinterest
$35.04 /

-0.85 (-2.37%)

FB Facebook
$268.52 /

+3.295 (+1.24%)

Options
Unusual call flow in option market yesterday » 07:35
08/10/20
08/10
07:35
08/10/20
07:35
FB

Facebook

$268.52 /

+3.295 (+1.24%)

Notable call activity was…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
FB Facebook
$268.52 /

+3.295 (+1.24%)

FB Facebook
$268.52 /

+3.295 (+1.24%)

06:55 Today Mizuho
Facebook price target raised to $315 from $285 at Mizuho
08/05/20 HSBC
HSBC bumps up Facebook target to $195, maintains Reduce rating
08/04/20 Argus
Facebook price target raised to $300 from $270 at Argus
08/03/20 Wedbush
Wedbush sees a TikTok deal as big bet from Microsoft on social media space
FB Facebook
$268.52 /

+3.295 (+1.24%)

FB Facebook
$268.52 /

+3.295 (+1.24%)

FB Facebook
$268.52 /

+3.295 (+1.24%)

FB Facebook
$268.52 /

+3.295 (+1.24%)

Initiation
Credit Suisse bullish on GoHealth, initiates with an Outperform » 07:34
08/10/20
08/10
07:34
08/10/20
07:34
GOCO

GoHealth

$17.26 /

+0.26 (+1.53%)

As previously reported,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GOCO GoHealth
$17.26 /

+0.26 (+1.53%)

GOCO GoHealth
$17.26 /

+0.26 (+1.53%)

07:22 Today Evercore ISI
GoHealth initiated with an Outperform at Evercore ISI
07:21 Today Truist
GoHealth initiated with a Buy at Truist
06:48 Today RBC Capital
GoHealth initiated with an Outperform at RBC Capital
06:45 Today Cantor Fitzgerald
GoHealth initiated with an Overweight at Cantor Fitzgerald
  • 15
    Jul
GOCO GoHealth
$17.26 /

+0.26 (+1.53%)

GOCO GoHealth
$17.26 /

+0.26 (+1.53%)

Earnings
Synchronoss reports Q2 EPS 16c, consensus (21c) » 07:34
08/10/20
08/10
07:34
08/10/20
07:34
SNCR

Synchronoss

$3.08 /

+0.02 (+0.65%)

Reports Q revenue $76.5M,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SNCR Synchronoss
$3.08 /

+0.02 (+0.65%)

SNCR Synchronoss
$3.08 /

+0.02 (+0.65%)

07/16/20 Northland
Northland says AT&T cloud could become Synchronoss' second largest customer
05/26/20 Northland
Synchronoss initiated with an Outperform at Northland
05/11/20 Roth Capital
Synchronoss price target lowered to $9 from $13 at Roth Capital
12/20/19 Roth Capital
Roth says Synchronoss opportunity in advanced messaging looks underappreciated
SNCR Synchronoss
$3.08 /

+0.02 (+0.65%)

Hot Stocks
Precigen announces results from Phase 1b/2a study of AG019 ActoBiotics » 07:34
08/10/20
08/10
07:34
08/10/20
07:34
PGEN

Precigen

$4.87 /

+0.1 (+2.10%)

Precigen ActoBio, a…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
PGEN Precigen
$4.87 /

+0.1 (+2.10%)

PGEN Precigen
$4.87 /

+0.1 (+2.10%)

05/08/20
Fly Intel: Top analyst initiations
05/08/20 H.C. Wainwright
Precigen initiated with a Buy at H.C. Wainwright
PGEN Precigen
$4.87 /

+0.1 (+2.10%)

Hot Stocks
Hexindai announces ADS ratio change » 07:33
08/10/20
08/10
07:33
08/10/20
07:33
HX

Hexindai

$0.70 /

-0.0219 (-3.05%)

Hexindai announced that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
HX Hexindai
$0.70 /

-0.0219 (-3.05%)

Hot Stocks
Momenta says Mylan expects U.S. submission for M710 in 2021 » 07:33
08/10/20
08/10
07:33
08/10/20
07:33
MYL

Mylan

$16.35 /

-0.07 (-0.43%)

, MNTA

Momenta

$32.94 /

+0.5 (+1.54%)

Mylan continues its…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MYL Mylan
$16.35 /

-0.07 (-0.43%)

MNTA Momenta
$32.94 /

+0.5 (+1.54%)

MYL Mylan
$16.35 /

-0.07 (-0.43%)

07/27/20 Goldman Sachs
Mylan initiated with Not Rated at Goldman Sachs
06/18/20 Raymond James
Raymond James says Mylan win over Biogen has 'no real apparent financial upside'
06/18/20 Wedbush
Patent ruling 'creates a significant issue' for Biogen, says Wedbush
03/25/20 Cantor Fitzgerald
Few concerns weighing on Mylan shares today, says Cantor Fitzgerald
MNTA Momenta
$32.94 /

+0.5 (+1.54%)

08/03/20 Cowen
Momenta upgraded to Outperform from Market Perform at Cowen
07/29/20 H.C. Wainwright
Momenta price target raised to $50 from $46 at H.C. Wainwright
06/17/20 SunTrust
Momenta price target raised to $57 from $50 at SunTrust
06/17/20 SunTrust
Immunovant price target raised to $36 from $24 at SunTrust
MYL Mylan
$16.35 /

-0.07 (-0.43%)

MNTA Momenta
$32.94 /

+0.5 (+1.54%)

  • 12
    Dec
MYL Mylan
$16.35 /

-0.07 (-0.43%)

MYL Mylan
$16.35 /

-0.07 (-0.43%)

MNTA Momenta
$32.94 /

+0.5 (+1.54%)

MYL Mylan
$16.35 /

-0.07 (-0.43%)

Earnings
Stoke Therapeutics reports Q2 EPS (39c), consensus (35c) » 07:33
08/10/20
08/10
07:33
08/10/20
07:33
STOK

Stoke Therapeutics

$26.82 /

+0.5 (+1.90%)

"Today we are…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
STOK Stoke Therapeutics
$26.82 /

+0.5 (+1.90%)

STOK Stoke Therapeutics
$26.82 /

+0.5 (+1.90%)

02/07/20 Guggenheim
Guggenheim starts NeuBase Therapeutics at Buy with $13 price target
12/17/19 Wedbush
Stoke Therapeutics initiated with an Outperform at Wedbush
11/12/19
Fly Intel: Top five analyst initiations
11/12/19 BTIG
Stoke Therapeutics initiated with a Buy at BTIG
STOK Stoke Therapeutics
$26.82 /

+0.5 (+1.90%)

Hot Stocks
Momenta exploring utility of necuparanib for COVID-19 » 07:32
08/10/20
08/10
07:32
08/10/20
07:32
MNTA

Momenta

$32.94 /

+0.5 (+1.54%)

The Company is currently…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MNTA Momenta
$32.94 /

+0.5 (+1.54%)

MNTA Momenta
$32.94 /

+0.5 (+1.54%)

08/03/20 Cowen
Momenta upgraded to Outperform from Market Perform at Cowen
07/29/20 H.C. Wainwright
Momenta price target raised to $50 from $46 at H.C. Wainwright
06/17/20 SunTrust
Momenta price target raised to $57 from $50 at SunTrust
06/17/20 SunTrust
Immunovant price target raised to $36 from $24 at SunTrust
MNTA Momenta
$32.94 /

+0.5 (+1.54%)

  • 12
    Dec
MNTA Momenta
$32.94 /

+0.5 (+1.54%)

Hot Stocks
Cummins, Navistar announce new long-term agreement » 07:32
08/10/20
08/10
07:32
08/10/20
07:32
CMI

Cummins

$199.17 /

+3.155 (+1.61%)

, NAV

Navistar

$33.74 /

+0.23 (+0.69%)

Cummins (CMI) and…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CMI Cummins
$199.17 /

+3.155 (+1.61%)

NAV Navistar
$33.74 /

+0.23 (+0.69%)

CMI Cummins
$199.17 /

+3.155 (+1.61%)

07/29/20 Credit Suisse
Cummins price target raised to $244 from $203 at Credit Suisse
07/29/20 RBC Capital
Cummins price target raised to $210 from $165 at RBC Capital
07/29/20 Loop Capital
Cummins price target raised to $160 from $130 at Loop Capital
07/20/20 Wells Fargo
Cummins price target raised to $205 from $190 at Wells Fargo
NAV Navistar
$33.74 /

+0.23 (+0.69%)

07/16/20 OTR Global
Navistar upgraded to Mixed from Negative at OTR Global
07/07/20 Wolfe Research
Navistar upgraded to Outperform from Peer Perform at Wolfe Research
06/17/20 JPMorgan
North America Class 8 retail sales down 61% in May, says JPMorgan
06/05/20
Fly Intel: Top five analyst upgrades
CMI Cummins
$199.17 /

+3.155 (+1.61%)

NAV Navistar
$33.74 /

+0.23 (+0.69%)

CMI Cummins
$199.17 /

+3.155 (+1.61%)

NAV Navistar
$33.74 /

+0.23 (+0.69%)

NAV Navistar
$33.74 /

+0.23 (+0.69%)

CMI Cummins
$199.17 /

+3.155 (+1.61%)

Hot Stocks
Momenta plans to submit IND for M267 in 2021 » 07:31
08/10/20
08/10
07:31
08/10/20
07:31
MNTA

Momenta

$32.94 /

+0.5 (+1.54%)

IND-enabling studies are…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MNTA Momenta
$32.94 /

+0.5 (+1.54%)

MNTA Momenta
$32.94 /

+0.5 (+1.54%)

08/03/20 Cowen
Momenta upgraded to Outperform from Market Perform at Cowen
07/29/20 H.C. Wainwright
Momenta price target raised to $50 from $46 at H.C. Wainwright
06/17/20 SunTrust
Momenta price target raised to $57 from $50 at SunTrust
06/17/20 SunTrust
Immunovant price target raised to $36 from $24 at SunTrust
MNTA Momenta
$32.94 /

+0.5 (+1.54%)

  • 12
    Dec
MNTA Momenta
$32.94 /

+0.5 (+1.54%)

Hot Stocks
Momenta says CSL plans to introduce M230 Phase 1 program this year » 07:31
08/10/20
08/10
07:31
08/10/20
07:31
MNTA

Momenta

$32.94 /

+0.5 (+1.54%)

Momenta's…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MNTA Momenta
$32.94 /

+0.5 (+1.54%)

MNTA Momenta
$32.94 /

+0.5 (+1.54%)

08/03/20 Cowen
Momenta upgraded to Outperform from Market Perform at Cowen
07/29/20 H.C. Wainwright
Momenta price target raised to $50 from $46 at H.C. Wainwright
06/17/20 SunTrust
Momenta price target raised to $57 from $50 at SunTrust
06/17/20 SunTrust
Immunovant price target raised to $36 from $24 at SunTrust
MNTA Momenta
$32.94 /

+0.5 (+1.54%)

  • 12
    Dec
MNTA Momenta
$32.94 /

+0.5 (+1.54%)

Recommendations
Albemarle price target raised to $87 from $65 at Truist » 07:30
08/10/20
08/10
07:30
08/10/20
07:30
ALB

Albemarle

$84.42 /

+1.12 (+1.34%)

Truist analyst James…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ALB Albemarle
$84.42 /

+1.12 (+1.34%)

ALB Albemarle
$84.42 /

+1.12 (+1.34%)

07/27/20
Fly Intel: Top five analyst downgrades
07/27/20 Berenberg
Albemarle downgraded to Sell following rally off lows at Berenberg
07/27/20 Berenberg
Albemarle downgraded to Sell from Hold at Berenberg
06/26/20
Fly Intel: Top five analyst upgrades
ALB Albemarle
$84.42 /

+1.12 (+1.34%)

ALB Albemarle
$84.42 /

+1.12 (+1.34%)

ALB Albemarle
$84.42 /

+1.12 (+1.34%)

ALB Albemarle
$84.42 /

+1.12 (+1.34%)

Hot Stocks
Momenta expects Phase 2 study of M254 to commence in 2021 » 07:30
08/10/20
08/10
07:30
08/10/20
07:30
MNTA

Momenta

$32.94 /

+0.5 (+1.54%)

Patient enrollment is…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MNTA Momenta
$32.94 /

+0.5 (+1.54%)

MNTA Momenta
$32.94 /

+0.5 (+1.54%)

08/03/20 Cowen
Momenta upgraded to Outperform from Market Perform at Cowen
07/29/20 H.C. Wainwright
Momenta price target raised to $50 from $46 at H.C. Wainwright
06/17/20 SunTrust
Momenta price target raised to $57 from $50 at SunTrust
06/17/20 SunTrust
Immunovant price target raised to $36 from $24 at SunTrust
MNTA Momenta
$32.94 /

+0.5 (+1.54%)

  • 12
    Dec
MNTA Momenta
$32.94 /

+0.5 (+1.54%)

Hot Stocks
Momenta to initiate Phase 3 nipocalimab study in 1Q21 » 07:30
08/10/20
08/10
07:30
08/10/20
07:30
MNTA

Momenta

$32.94 /

+0.5 (+1.54%)

In June 2020, Momenta…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MNTA Momenta
$32.94 /

+0.5 (+1.54%)

MNTA Momenta
$32.94 /

+0.5 (+1.54%)

08/03/20 Cowen
Momenta upgraded to Outperform from Market Perform at Cowen
07/29/20 H.C. Wainwright
Momenta price target raised to $50 from $46 at H.C. Wainwright
06/17/20 SunTrust
Momenta price target raised to $57 from $50 at SunTrust
06/17/20 SunTrust
Immunovant price target raised to $36 from $24 at SunTrust
MNTA Momenta
$32.94 /

+0.5 (+1.54%)

  • 12
    Dec
MNTA Momenta
$32.94 /

+0.5 (+1.54%)

Hot Stocks
Momenta sees 2020 non-GAAP operating expenses $200M-$220M  07:29
08/10/20
08/10
07:29
08/10/20
07:29
MNTA

Momenta

$32.94 /

+0.5 (+1.54%)

 
ShowHide Related Items >><<
MNTA Momenta
$32.94 /

+0.5 (+1.54%)

MNTA Momenta
$32.94 /

+0.5 (+1.54%)

08/03/20 Cowen
Momenta upgraded to Outperform from Market Perform at Cowen
07/29/20 H.C. Wainwright
Momenta price target raised to $50 from $46 at H.C. Wainwright
06/17/20 SunTrust
Momenta price target raised to $57 from $50 at SunTrust
06/17/20 SunTrust
Immunovant price target raised to $36 from $24 at SunTrust
MNTA Momenta
$32.94 /

+0.5 (+1.54%)

  • 12
    Dec
MNTA Momenta
$32.94 /

+0.5 (+1.54%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.